ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients

NEXT STORY
Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101
PREV STORY
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxart Announces Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program

author_avatar
NASDAQ Market News

Chiasma Achieves 50% of Target Patients Randomized in CHIASMA OPTIMAL Phase 3 Clinical Trial of Octreotide Capsules in Patients with Acromegaly

Company Expects Randomization to be Completed by End of 2018 and Anticipates Release of ...

author_avatar
NASDAQ Market News

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments

author_avatar
NASDAQ Market News